These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7242010)

  • 21. Failure of lithium treatment in established tardive dyskinesia.
    MacKay AV; Sheppard GP; Saha BK; Motley B; Johnson AL; Marsden CD
    Psychol Med; 1980 Aug; 10(3):583-7. PubMed ID: 7003639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulpiride in tardive dyskinesia.
    Casey DE; Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
    Libov I; Miodownik C; Bersudsky Y; Dwolatzky T; Lerner V
    J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia.
    de la Fuente-Fernández R
    Neurology; 1998 Apr; 50(4):1134-5. PubMed ID: 9566407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of sodium valproate on tardive dyskinesia--revisited.
    Fisk GG; York SM
    Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium valproate in tardive dyskinesia.
    Casey DE; Hammerstad JP
    J Clin Psychiatry; 1979 Nov; 40(11):483-5. PubMed ID: 385585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meclofenoxate therapy in tardive dyskinesia: a preliminary report.
    Izumi K; Tominaga H; Koja T; Nomoto M; Shimizu T; Sonoda H; Imamura K; Igata A; Fukuda T
    Biol Psychiatry; 1986 Feb; 21(2):151-60. PubMed ID: 2868761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-tryptophan in neuroleptic-induced tardive dyskinesia.
    Sandyk R; Bamford CR; Khan I; Fisher H
    Int J Neurosci; 1988 Sep; 42(1-2):127-30. PubMed ID: 2905343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of gamma-vinyl GABA in tardive dyskinesia.
    Korsgaard S; Casey DE; Gerlach J
    Psychiatry Res; 1983 Apr; 8(4):261-9. PubMed ID: 6136054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
    J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caudate atrophy in irreversible tardive dyskinesia (a pneumoencephalographic study).
    Pandurangi AK; Devi V; Channabasavanna SM
    J Clin Psychiatry; 1980 Jul; 41(7):229-31. PubMed ID: 6967063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metoclopramide and haloperidol in tardive dyskinesia.
    Bateman DN; Dutta DK; McClelland HA; Rawlins MD
    Br J Psychiatry; 1979 Dec; 135():505-8. PubMed ID: 43755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders.
    Stahl SM; Thornton JE; Simpson ML; Berger PA; Napoliello MJ
    Biol Psychiatry; 1985 Aug; 20(8):888-93. PubMed ID: 3861199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of tardive dyskinesia: preliminary report on use of tetrabenazine.
    Watson MW; Skelton D; Jamali F
    Can J Psychiatry; 1988 Feb; 33(1):11-3. PubMed ID: 2965967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.